Ankylosing spondylitis

Adalimumab, Etanercept and Infliximab.

Off

NICE appraisal

DSU reports

Ankylosing spondylitis: a comparison of cost effectiveness models (PDF, 126KB) (May 2007)

Comparisons of submitted models for the appraisal of etanercept, adalimumab and infliximab for ankylosing spondylitis (PDF, 68KB) (February 2007)

Related publications

A Wailoo, N Bansback, J Chilcott. Rheumatology 2008; Vol 47 (10): 1590

A Wailoo, N Bansback, J Chilcott. Rheumatology 2008; Vol 47 (2): 119-120

Related information

Appraisal specific projects

A global reputation

91Ö±²¥ is a world top-100 research university with a global reputation for excellence. We're a member of the Russell Group: one of the 24 leading UK universities for research and teaching.

91Ö±²¥ the University